Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

The Unsolved Link of Genetic Markers and Crohn's Disease Progression: A North American Cohort Experience.

O'Donnell S, Borowski K, Espin-Garcia O, Milgrom R, Kabakchiev B, Stempak J, Panikkath D, Eksteen B, Xu W, Steinhart AH, Kaplan GG, McGovern DPB, Silverberg MS.

Inflamm Bowel Dis. 2019 Aug 20;25(9):1541-1549. doi: 10.1093/ibd/izz016.

PMID:
30801121
2.

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.

Trauner M, Gulamhusein A, Hameed B, Caldwell S, Shiffman ML, Landis C, Eksteen B, Agarwal K, Muir A, Rushbrook S, Lu X, Xu J, Chuang JC, Billin AN, Li G, Chung C, Subramanian GM, Myers RP, Bowlus CL, Kowdley KV.

Hepatology. 2019 Sep;70(3):788-801. doi: 10.1002/hep.30509. Epub 2019 Mar 10.

3.

Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease.

Reyes JL, Vannan DT, Eksteen B, Avelar IJ, Rodríguez T, González MI, Mendoza AV.

Mediators Inflamm. 2018 Aug 12;2018:2532314. doi: 10.1155/2018/2532314. eCollection 2018. Review.

4.

Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.

Muir AJ, Levy C, Janssen HLA, Montano-Loza AJ, Shiffman ML, Caldwell S, Luketic V, Ding D, Jia C, McColgan BJ, McHutchison JG, Mani Subramanian G, Myers RP, Manns M, Chapman R, Afdhal NH, Goodman Z, Eksteen B, Bowlus CL; GS-US-321-0102 Investigators.

Hepatology. 2019 Feb;69(2):684-698. doi: 10.1002/hep.30237. Epub 2019 Jan 11.

PMID:
30153359
5.

Neutralization of IL-15 abrogates experimental immune-mediated cholangitis in diet-induced obese mice.

Reyes JL, Vannan DT, Vo T, Gulamhusein A, Beck PL, Reimer RA, Eksteen B.

Sci Rep. 2018 Feb 15;8(1):3127. doi: 10.1038/s41598-018-21112-7.

6.

Primary Sclerosing Cholangitis Is Not Rare Among Blacks in a Multicenter North American Consortium.

Goldberg DS, Levy C, Yimam K, Gordon SC, Forman L, Verna E, Yu L, Rahimi R, Schwarz K, Eksteen B, Pratt D, Boyer JL, Assis D, Bowlus C.

Clin Gastroenterol Hepatol. 2018 Apr;16(4):591-593. doi: 10.1016/j.cgh.2017.10.028. Epub 2017 Nov 2. No abstract available.

7.

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.

Alberts R, de Vries EMG, Goode EC, Jiang X, Sampaziotis F, Rombouts K, Böttcher K, Folseraas T, Weismüller TJ, Mason AL, Wang W, Alexander G, Alvaro D, Bergquist A, Björkström NK, Beuers U, Björnsson E, Boberg KM, Bowlus CL, Bragazzi MC, Carbone M, Chazouillères O, Cheung A, Dalekos G, Eaton J, Eksteen B, Ellinghaus D, Färkkilä M, Festen EAM, Floreani A, Franceschet I, Gotthardt DN, Hirschfield GM, Hoek BV, Holm K, Hohenester S, Hov JR, Imhann F, Invernizzi P, Juran BD, Lenzen H, Lieb W, Liu JZ, Marschall HU, Marzioni M, Melum E, Milkiewicz P, Müller T, Pares A, Rupp C, Rust C, Sandford RN, Schramm C, Schreiber S, Schrumpf E, Silverberg MS, Srivastava B, Sterneck M, Teufel A, Vallier L, Verheij J, Vila AV, Vries B, Zachou K; International PSC Study Group, The UK PSC Consortium, Chapman RW, Manns MP, Pinzani M, Rushbrook SM, Lazaridis KN, Franke A, Anderson CA, Karlsen TH, Ponsioen CY, Weersma RK.

Gut. 2018 Aug;67(8):1517-1524. doi: 10.1136/gutjnl-2016-313598. Epub 2017 Aug 4.

8.

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

Henriksen EKK, Viken MK, Wittig M, Holm K, Folseraas T, Mucha S, Melum E, Hov JR, Lazaridis KN, Juran BD, Chazouillères O, Färkkilä M, Gotthardt DN, Invernizzi P, Carbone M, Hirschfield GM, Rushbrook SM, Goode E; UK-PSC Consortium, Ponsioen CY, Weersma RK, Eksteen B, Yimam KK, Gordon SC, Goldberg D, Yu L, Bowlus CL, Franke A, Lie BA, Karlsen TH.

HLA. 2017 Oct;90(4):228-233. doi: 10.1111/tan.13076. Epub 2017 Jul 11.

PMID:
28695657
9.

The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study.

Kuenzig ME, Yim J, Coward S, Eksteen B, Seow CH, Barnabe C, Barkema HW, Silverberg MS, Lakatos PL, Beck PL, Fedorak R, Dieleman LA, Madsen K, Panaccione R, Ghosh S, Kaplan GG.

EBioMedicine. 2017 Jul;21:188-196. doi: 10.1016/j.ebiom.2017.06.012. Epub 2017 Jun 16. Review.

10.

Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort study.

Lau KCK, Shaheen AA, Aspinall AA, Ricento Ba T, Qureshi Mba K, Congly SE, Borman MA, Jayakumar S, Eksteen B, Lee SS, Stinton L, Swain MG, Burak KW, Coffin CS.

CMAJ Open. 2017 Jun 6;5(2):E431-E436. doi: 10.9778/cmajo.20170002.

11.

Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A Population-based Case-Control Study.

Kuenzig ME, Barnabe C, Seow CH, Eksteen B, Negron ME, Rezaie A, Panaccione R, Benchimol EI, Sadatsafavi M, Aviña-Zubieta JA, Kaplan GG.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1405-1412.e3. doi: 10.1016/j.cgh.2017.02.042. Epub 2017 Mar 23.

12.

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.

Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN, Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C, Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg CP, Manns MP, Lindor KD, Hirschfield GM, Hansen BE, Boberg KM; International PSC Study Group.

Gastroenterology. 2017 Jun;152(8):1975-1984.e8. doi: 10.1053/j.gastro.2017.02.038. Epub 2017 Mar 6.

13.

Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.

de Vries EMG, Färkkilä M, Milkiewicz P, Hov JR, Eksteen B, Thorburn D, Chazouillères O, Pares A, Nygård S, Gilja OH, Wunsch E, Invernizzi P, Carbone M, Bernuzzi F, Boberg KM, Røsjø H, Rosenberg W, Beuers UH, Ponsioen CY, Karlsen TH, Vesterhus M.

Liver Int. 2017 Oct;37(10):1554-1561. doi: 10.1111/liv.13402. Epub 2017 Apr 13.

14.

Retraction notice to: PS124-Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (PSC) in Individuals with Inflammatory Bowel Disease [J Hepatol 64 (2016) S199].

Eksteen B, Heatherington J, Oshiomogo J, Panaccione R, Kaplan G, Ghosh S.

J Hepatol. 2017 Jan;66(1):254. doi: 10.1016/j.jhep.2016.10.020. Epub 2016 Dec 15. No abstract available.

PMID:
28042931
15.

Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration.

Kuenzig ME, Lee SM, Eksteen B, Seow CH, Barnabe C, Panaccione R, Kaplan GG.

BMC Gastroenterol. 2016 Dec 21;16(1):143. doi: 10.1186/s12876-016-0555-8. Review.

16.

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.

Ji SG, Juran BD, Mucha S, Folseraas T, Jostins L, Melum E, Kumasaka N, Atkinson EJ, Schlicht EM, Liu JZ, Shah T, Gutierrez-Achury J, Boberg KM, Bergquist A, Vermeire S, Eksteen B, Durie PR, Farkkila M, Müller T, Schramm C, Sterneck M, Weismüller TJ, Gotthardt DN, Ellinghaus D, Braun F, Teufel A, Laudes M, Lieb W, Jacobs G, Beuers U, Weersma RK, Wijmenga C, Marschall HU, Milkiewicz P, Pares A, Kontula K, Chazouillères O, Invernizzi P, Goode E, Spiess K, Moore C, Sambrook J, Ouwehand WH, Roberts DJ, Danesh J, Floreani A, Gulamhusein AF, Eaton JE, Schreiber S, Coltescu C, Bowlus CL, Luketic VA, Odin JA, Chopra KB, Kowdley KV, Chalasani N, Manns MP, Srivastava B, Mells G, Sandford RN, Alexander G, Gaffney DJ, Chapman RW, Hirschfield GM, de Andrade M; UK-PSC Consortium; International IBD Genetics Consortium; International PSC Study Group, Rushbrook SM, Franke A, Karlsen TH, Lazaridis KN, Anderson CA.

Nat Genet. 2017 Feb;49(2):269-273. doi: 10.1038/ng.3745. Epub 2016 Dec 19.

17.

Association between Air Pollution and the Development of Rheumatic Disease: A Systematic Review.

Sun G, Hazlewood G, Bernatsky S, Kaplan GG, Eksteen B, Barnabe C.

Int J Rheumatol. 2016;2016:5356307. Epub 2016 Oct 25. Review.

18.

RETRACTED: Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease.

Eksteen B, Heatherington J, Oshiomogo J, Panaccione R, Kaplan G, Ghosh S.

J Hepatol. 2016;64(2S):S199. doi: 10.1016/S0168-8278(16)01707-4. Epub 2016 Sep 22. Retraction in: J Hepatol. 2017 Jan;66(1):254.

PMID:
27769522
19.

Smoking Is Associated with an Increased Risk for Surgery in Diverticulitis: A Case Control Study.

Diamant MJ, Schaffer S, Coward S, Kuenzig ME, Hubbard J, Eksteen B, Heitman S, Panaccione R, Ghosh S, Kaplan GG.

PLoS One. 2016 Jul 28;11(7):e0153871. doi: 10.1371/journal.pone.0153871. eCollection 2016.

20.

Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation.

Reid DT, Reyes JL, McDonald BA, Vo T, Reimer RA, Eksteen B.

PLoS One. 2016 Jul 25;11(7):e0159524. doi: 10.1371/journal.pone.0159524. eCollection 2016.

21.

Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

Liu Y, Hazlewood GS, Kaplan GG, Eksteen B, Barnabe C.

Arthritis Care Res (Hoboken). 2017 Feb;69(2):157-165. doi: 10.1002/acr.22932. Epub 2016 Dec 31. Review.

22.

The Association of Smoking and Surgery in Inflammatory Bowel Disease is Modified by Age at Diagnosis.

Frolkis AD, de Bruyn J, Jette N, Lowerison M, Engbers J, Ghali W, Lewis JD, Vallerand I, Patten S, Eksteen B, Barnabe C, Panaccione R, Ghosh S, Wiebe S, Kaplan GG.

Clin Transl Gastroenterol. 2016 Apr 21;7:e165. doi: 10.1038/ctg.2016.21.

23.

Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease.

Reid DT, McDonald B, Khalid T, Vo T, Schenck LP, Surette MG, Beck PL, Reimer RA, Probert CS, Rioux KP, Eksteen B.

Biochim Biophys Acta. 2016 Jul;1862(7):1337-44. doi: 10.1016/j.bbadis.2016.04.005. Epub 2016 Apr 13.

24.

Selective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumab.

Petkau JM, Eksteen B.

Biologics. 2016 Mar 9;10:33-52. doi: 10.2147/BTT.S71679. eCollection 2016. Review.

25.

Predicting risk in primary biliary cholangitis.

Eksteen B.

Hepatology. 2016 Mar;63(3):697-9. doi: 10.1002/hep.28377. Epub 2016 Jan 14. No abstract available.

PMID:
26638198
26.

Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.

Lambert JE, Parnell JA, Eksteen B, Raman M, Bomhof MR, Rioux KP, Madsen KL, Reimer RA.

BMC Gastroenterol. 2015 Dec 3;15:169. doi: 10.1186/s12876-015-0400-5.

27.

The Gut-Liver Axis in Primary Sclerosing Cholangitis.

Eksteen B.

Clin Liver Dis. 2016 Feb;20(1):1-14. doi: 10.1016/j.cld.2015.08.012. Epub 2015 Sep 26. Review.

PMID:
26593287
28.

Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.

Coombes JD, Choi SS, Swiderska-Syn M, Manka P, Reid DT, Palma E, Briones-Orta MA, Xie G, Younis R, Kitamura N, Della Peruta M, Bitencourt S, Dollé L, Oo YH, Mi Z, Kuo PC, Williams R, Chokshi S, Canbay A, Claridge LC, Eksteen B, Diehl AM, Syn WK.

Biochim Biophys Acta. 2016 Jan;1862(1):135-44. doi: 10.1016/j.bbadis.2015.10.028. Epub 2015 Oct 31.

29.

Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.

Kevans D, Tyler AD, Holm K, Jørgensen KK, Vatn MH, Karlsen TH, Kaplan GG, Eksteen B, Gevers D, Hov JR, Silverberg MS.

J Crohns Colitis. 2016 Mar;10(3):330-7. doi: 10.1093/ecco-jcc/jjv204. Epub 2015 Nov 2.

30.

Murine models provide insight to the development of non-alcoholic fatty liver disease.

Reid DT, Eksteen B.

Nutr Res Rev. 2015 Dec;28(2):133-142. Epub 2015 Oct 23.

PMID:
26494024
31.

TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.

Volodko N, Salla M, Eksteen B, Fedorak RN, Huynh HQ, Baksh S.

World J Gastroenterol. 2015 Sep 28;21(36):10358-66. doi: 10.3748/wjg.v21.i36.10358.

32.

Clinical predictors of thiopurine-related adverse events in Crohn's disease.

Moran GW, Dubeau MF, Kaplan GG, Yang H, Eksteen B, Ghosh S, Panaccione R.

World J Gastroenterol. 2015 Jul 7;21(25):7795-804. doi: 10.3748/wjg.v21.i25.7795.

33.

Postoperative Mortality Among Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis of Population-Based Studies.

Singh S, Al-Darmaki A, Frolkis AD, Seow CH, Leung Y, Novak KL, Ghosh S, Eksteen B, Panaccione R, Kaplan GG.

Gastroenterology. 2015 Oct;149(4):928-37. doi: 10.1053/j.gastro.2015.06.001. Epub 2015 Jun 6. Review.

PMID:
26055136
34.

Serrated adenoma prevalence in inflammatory bowel disease surveillance colonoscopy, and characteristics revealed by chromoendoscopy and virtual chromoendoscopy.

Iacucci M, Hassan C, Fort Gasia M, Urbanski S, Gui X, Eksteen B, Eustace G, Kaplan GG, Panaccione R.

Can J Gastroenterol Hepatol. 2014 Dec;28(11):589-94.

35.

The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer.

Ward ST, Li KK, Hepburn E, Weston CJ, Curbishley SM, Reynolds GM, Hejmadi RK, Bicknell R, Eksteen B, Ismail T, Rot A, Adams DH.

Br J Cancer. 2015 Jan 20;112(2):319-28. doi: 10.1038/bjc.2014.572. Epub 2014 Nov 18.

36.

PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).

Stinton LM, Bentow C, Mahler M, Norman GL, Eksteen B, Mason AL, Kaplan GG, Lindkvist B, Hirschfield GM, Milkiewicz P, Cheung A, Janssen HL, Fritzler MJ.

PLoS One. 2014 Nov 14;9(11):e112877. doi: 10.1371/journal.pone.0112877. eCollection 2014.

37.

Colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluation.

Negrón ME, Kaplan GG, Barkema HW, Eksteen B, Clement F, Manns BJ, Coward S, Panaccione R, Ghosh S, Heitman SJ.

Inflamm Bowel Dis. 2014 Nov;20(11):2046-55. doi: 10.1097/MIB.0000000000000181.

PMID:
25230162
38.

Targeting of gut specific leucocyte recruitment in IBD by vedolizumab.

Eksteen B.

Gut. 2015 Jan;64(1):8-10. doi: 10.1136/gutjnl-2014-307397. Epub 2014 Jun 19. No abstract available.

PMID:
24946955
39.

Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.

Coombes JD, Swiderska-Syn M, Dollé L, Reid D, Eksteen B, Claridge L, Briones-Orta MA, Shetty S, Oo YH, Riva A, Chokshi S, Papa S, Mi Z, Kuo PC, Williams R, Canbay A, Adams DH, Diehl AM, van Grunsven LA, Choi SS, Syn WK.

Gut. 2015 Jul;64(7):1120-31. doi: 10.1136/gutjnl-2013-306484. Epub 2014 Jun 5.

40.

Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis.

Eksteen B.

Br Med Bull. 2014 Jun;110(1):89-98. doi: 10.1093/bmb/ldu008. Epub 2014 May 2. Review.

PMID:
24795363
41.

Characterization of animal models for primary sclerosing cholangitis (PSC).

Fickert P, Pollheimer MJ, Beuers U, Lackner C, Hirschfield G, Housset C, Keitel V, Schramm C, Marschall HU, Karlsen TH, Melum E, Kaser A, Eksteen B, Strazzabosco M, Manns M, Trauner M; International PSC Study Group (IPSCSG).

J Hepatol. 2014 Jun;60(6):1290-303. doi: 10.1016/j.jhep.2014.02.006. Epub 2014 Feb 19. Review.

42.

Vascular cell adhesion molecule 1 expression by biliary epithelium promotes persistence of inflammation by inhibiting effector T-cell apoptosis.

Afford SC, Humphreys EH, Reid DT, Russell CL, Banz VM, Oo Y, Vo T, Jenne C, Adams DH, Eksteen B.

Hepatology. 2014 May;59(5):1932-43. doi: 10.1002/hep.26965. Epub 2014 Mar 27.

PMID:
24338559
43.

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen MM, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, Sterneck M, Teufel A, Mason AL, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich SS, Thompson WK, Schork AJ, Næss S, Thomsen I, Mayr G, König IR, Hveem K, Cleynen I, Gutierrez-Achury J, Ricaño-Ponce I, van Heel D, Björnsson E, Sandford RN, Durie PR, Melum E, Vatn MH, Silverberg MS, Duerr RH, Padyukov L, Brand S, Sans M, Annese V, Achkar JP, Boberg KM, Marschall HU, Chazouillères O, Bowlus CL, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M; UK-PSCSC Consortium, Rioux JD, Alexander G, Bergquist A, Cho J, Schreiber S, Manns MP, Färkkilä M, Dale AM, Chapman RW, Lazaridis KN; International PSC Study Group, Franke A, Anderson CA, Karlsen TH; International IBD Genetics Consortium.

Nat Genet. 2013 Jun;45(6):670-5. doi: 10.1038/ng.2616. Epub 2013 Apr 21.

44.

Monitoring hepatitis C infection in the liver allograft.

Eksteen B.

Can J Gastroenterol. 2013 Mar;27(3):129-30. No abstract available.

45.

Role of IL-17A and neutrophils in fibrosis in experimental hypersensitivity pneumonitis.

Hasan SA, Eksteen B, Reid D, Paine HV, Alansary A, Johannson K, Gwozd C, Goring KA, Vo T, Proud D, Kelly MM.

J Allergy Clin Immunol. 2013 Jun;131(6):1663-73. doi: 10.1016/j.jaci.2013.01.015. Epub 2013 Feb 27.

PMID:
23453796
46.

CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver.

Oo YH, Banz V, Kavanagh D, Liaskou E, Withers DR, Humphreys E, Reynolds GM, Lee-Turner L, Kalia N, Hubscher SG, Klenerman P, Eksteen B, Adams DH.

J Hepatol. 2012 Nov;57(5):1044-51. doi: 10.1016/j.jhep.2012.07.008. Epub 2012 Jul 14.

47.

[Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults].

Claridge LC, Eksteen B, Smith A, Shah T, Holt AP.

Praxis (Bern 1994). 2011 Jul 27;100(15):923-6. doi: 10.1024/1661-8157/a000615. German. No abstract available.

PMID:
21792808
48.

Infections and the liver.

Eksteen B.

Dig Dis. 2011;29(2):184-90. doi: 10.1159/000323884. Epub 2011 Jul 5. Review.

PMID:
21734383
49.

Clonal analysis reveals uniformity in the molecular profile and lineage potential of CCR9(+) and CCR9(-) thymus-settling progenitors.

Desanti GE, Jenkinson WE, Parnell SM, Boudil A, Gautreau-Rolland L, Eksteen B, Ezine S, Lane PJ, Jenkinson EJ, Anderson G.

J Immunol. 2011 May 1;186(9):5227-35. doi: 10.4049/jimmunol.1002686. Epub 2011 Mar 18.

50.

Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults.

Claridge LC, Eksteen B, Smith A, Shah T, Holt AP.

BMJ. 2010 Dec 2;341:c6764. doi: 10.1136/bmj.c6764. No abstract available.

PMID:
21127120

Supplemental Content

Loading ...
Support Center